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Significance 
RNA Binding proteins (RBPs) play a central role in mediating post transcriptional regulation of genes. 
However less is understood about them and their regulatory mechanisms. In the present study, we 
present an analysis of 1344 human RBPs identified from recent experimental studies. We analyse their 
domain architecture, intrinsic disorder state, evolutionary conservation, protein expression across 
tissues and disease associations. This study should form a foundation for elucidation and discovery of 
the functions of RBPs and the cellular regulatory networks they control.  
Abstract 
RNA Binding Proteins (RBPs) play a central role in mediating post transcriptional regulation of genes. 
However less is understood about them and their regulatory mechanisms. In this study, we construct 
a catalogue of 1344 experimentally confirmed RBPs. The domain architecture of RBPs enabled us to 
classify them into three groups - Classical (29%), Non-classical (19%) and Unclassified (52%). A 
higher percentage of proteins with unclassified domains reveals the presence of various 
uncharacterised motifs that can potentially bind RNA. RBPs were found to be highly disordered 
compared to non-RBPs (p<2.2e-16, Fisher’s exact test), suggestive of a dynamic regulatory role of 
RBPs in cellular signalling and homeostasis. Evolutionary analysis in 62 different species showed that 
RBPs are highly conserved compared to non-RBPs (p<2.2e-16, Wilcox-test), reflecting the 
conservation of various biological processes like mRNA splicing and ribosome biogenesis. The 
expression patterns of RBPs from human proteome map revealed that ~40% of them are ubiquitously 
expressed and ~60% are tissue-specific. RBPs were also seen to be highly associated with several 
neurological disorders, cancer and inflammatory diseases.  Anatomical contexts like B cells, T-cells, 
fetal liver and fetal brain were found to be strongly enriched for RBPs, implying a prominent role of 
RBPs in immune responses and different developmental stages. The catalogue and meta-analysis 
presented here should form a foundation for furthering our understanding of RBPs and the cellular 









Cellular processes are controlled by several genes; expression of which is regulated at different levels 
by various cellular entities. In eukaryotes, gene regulation is a complex multilevel process comprising 
of -- transcriptional, post-transcriptional and post-translational control. Although the regulation at 
transcriptional and post-translational levels is increasingly being understood, protein machinery and 
the mechanisms underlying the post-transcriptional regulation still remain to be elucidated. One of 
the pivotal players that are responsible for post-transcriptional regulatory control in eukaryotic 
organisms are the RNA binding proteins (RBPs). RBPs bind single or double stranded RNA and 
determine their fate from synthesis to decay [1-5]. They possess one or more domains that can 
recognize RNA in a sequence specific manner and hence conferring different binding affinities and 
specificities. In addition to these domains that can directly bind RNA, RBPs also contain auxiliary 
domains that mediate interactions with other proteins [6]. When bound to an mRNA, these proteins 
control all the major steps of an mRNA’s life, including splicing, export, localization, translation and 
degradation [1, 3, 4]. Due to their multi-functionality, RBPs become the most prominent of the post 
transcriptional machinery and any alteration in their function can cause deleterious effects which 
could lead to numerous complex disorders [2, 7, 8]. Hence, it becomes important to understand the 
structural and functional characteristics of RBPs in humans. Increasing interest in RBPs has led to the 
development of various experimental protocols like SELEX (systematic evolution of ligands by 
exponential enrichment) [9, 10], CLIP [11], PAR-CLIP [12, 13], iCLIP [14] and RNA compete [15], to 
identify the binding specificities of RBPs; thus adding context and dynamics to the regulation of gene 
expression at post-transcriptional level.  
In this study, we construct a catalogue of 1344 genes encoding for RBPs in the human genome 
(Supplementary Table 1): identified from recent high-throughput screens including the mRNA 
interactome of proliferating HeLa cells through interactome capture [1], mRNA –bound proteome in 
the human embryonic kidney cells identified using the photoreactive nucleotide-enhanced UV 
crosslinking and oligo(dT) purification approach , [16] , proteins with the ability to bind RNA from the 
RNA compete experiments [17], human orthologs of RBPs identified in the mouse embryonic stem 
cells through interactome capture [18] and RBPs with known binding specificities manually curated 
and reported in RBPDB [19] to perform a systematic survey of their domain composition, structural 
disorder, expression across 23 tissues, evolutionary conservation across 62 species and associated 
diseases by integrating diverse datasets in the public domain. This allowed us to not only uncover the 
domain architecture, expression and evolutionary dynamics of RNA-binding proteins but also provide 
novel insights into their roles in diverse human tissues and disease phenotypes. 
Materials and Methods 
Dataset of RNA-binding proteins 
We construct a catalogue of 1344 genes encoding for RBPs, identified from high-throughput screens 
by Castello et. al [1] , Baltz et. al [16], Ray et. al [17], human orthologs of RBPs identified in mouse 
embryonic stem cells by Kwon et. al[18] and RBPs reported in RBPDB[19] (Supplementary Table 1) 
for analysis in this study. Proteins annotated in ENSEMBL’s human genome build which were not 
identified as RBPs were considered as Non-RBPs.  
Annotation of domains for human proteins 
We used the ENSEMBL v73 biomart (http://www.ensembl.org) to annotate proteins with their 
corresponding  Pfam domains [20]. The superfamily annotations were obtained from the Superfamily 
database [21]. Domains in RBPs were categorized as classical and non-classical based on the 
definitions proposed by Castello et. al [1]. A domain occurring in an RBP which could not be classified 
as either a classical or non-classical was defined as “Unclassified”. The list of domains and 
superfamilies annotated for each RBP is shown in Supplementary Table 1.  Further, the enrichment of 
a given superfamily in RBPs was calculated using Fishers exact test taking Non-RBPs as a control set 
(“*” above a bar plot in Figure 2C indicates a significant p value (<0.05)). 
Intrinsic disorder of proteins 
Intrinsic structural disorder of proteins was predicted using IUPRED, which predicts disorder on a 
per-residue basis [22, 23]. The disorder score predicted by IUPRED was normalized by protein length 
to account for variations in different protein lengths when comparing predictions for various protein 
sets. A protein with a normalized score higher than 0.5 was considered to be disordered; this resulted 
in 30% of RBPs being highly disordered (Supplementary Table 2). To test if RBPs are highly 
disordered than the rest of the proteome, we calculated an enrichment for disorder in RBPs taking 
Non-RBPs as a control. 
Dataset of orthologs and evolutionary conservation 
We identified one-to-one, one-to-many and many-to many orthologs of RBPs across 62 different 
species from ENSEMBL (v73) (http://www.ensembl.org) (Supplementary Table 3). A hierarchical 
complete linkage clustering of the data was performed to identify groups of species and genes 
exhibiting common patterns of evolutionary conservation. Furthermore, the genes were binned into 
three classes based on their conservation level - high, medium and low. Genes with orthologs in more 
than 80% of the species were considered to be highly conserved. The next level of conservation is 
medium which comprises of genes with orthologs in more than 50% but less than 80% of the species. 
The low conservation class is comprised of genes having orthologs in less than 50% of the species. 
Tissue-wide expression profiles 
We examined the expression patterns of the RBP catalogue across 17 adult tissues and 6 
hematopoietic cells from the recently published human proteome catalogue [24]. Further, tissue 
specificity of the expression pattern was estimated using an index that varies between zero (for 
housekeeping genes) and one (observed for tissue specific genes)[25, 26]. We then calculated the 
tissue specificity scores for 17 well known housekeeping genes [27] and these resulted in an average 
tissue specificity score of 0.63. Based on this data, we termed genes with a tissue specificity score of at 
least 0.7 as tissue specific and those below 0.7 were termed ubiquitous. The difference between the 
expression levels of classical and non-classical RBPs was estimated using the Wilcox test.  
Disease Associations 
Disease annotations for RBPs were obtained from Malacards [28]. Based on these annotations, 
diseases enriched for RBPs were identified through hypergeometric probability considering Non-RBPs 
as a background. Upon filtering at p < 0.05 (Corrected p-value by Benjamini-Hochberg (BH) method), 
we identified 165 diseases to be significantly enriched for their associations with RBPs. Further, the 
anatomical contexts annotated for these 165 diseases were obtained from Malacards. The enrichment 
calculated as the odds ratio and corresponding p-value for each anatomical context was computed 
using the Fisher’s exact test. 
Results and Discussion 
Majority of the experimentally confirmed RBPs have uncharacterized RNA recognition 
domains 
RNA binding proteins associate with nascent RNA to aid in processing, export, transport and 
localization. The heterogeneity in the functions of these proteins is due to the presence of different 
RNA binding domains that recognize RNA. RBPs are built with multiple copies of a unique domain or 
a mosaic of different domains that confer specificity and affinity [29]. Hence, identifying the presence 
of various domains can provide clues to novel functions of RBPs. We annotated the RBP catalogue 
with existing Pfam [20] and Superfamily [21] definitions (Materials and Methods, Supplementary 
Table 1). Depending on the type of domain associated with an RBP and definitions provided by 
Castello et al [1], we categorized these proteins into “classical” and “non-classical”. Proteins which 
could not be categorised into either of the classes were termed ‘Unclassified’ in the present work. 
Using this classification, 29% constituted classical proteins, 19% non-classical and the remaining 52% 
formed the unclassified group (Figure 1A). The domain distribution of this catalogue (Figure 1B) 
illustrates the presence of various known and well-studied RNA binding domains like RRM (RNA 
recognition motif) [30], K-homology (KH) [31, 32], DEAD/DEAH box [33], dsrm [34], WD40 [35] in 
addition to unclassified domains like the Pkinase domain of EIF2AK2 that auto phosphorylates upon 
binding of  RNA to the dsRBD domain of EIF2AK2 [36, 37]. Also notable is the Calponin homology 
(CH) domain found in both cytoskeletal and signalling proteins [38]. Further, superfamilies like the 
RNA binding domain, KH domain type-1, CCCH zinc finger were found to be enriched in RBPs when 
compared to the Non-RBPs (p<2.2e-16, Fisher’s exact test) (Figure 1C). Interestingly, superfamilies 
like the P-loop containing nucleoside triphosphate hydrolase (P-loop NTH) (p-value<0.05, Fisher’s 
exact test), S-adenosyl,L-methionine dependent methyltransferases (p-value=9.52e-11, Fisher’s exact 
test), Spectrin repeat (p-value=3.92e-15, Fisher’s exact test) were found to be highly enriched in our 
RBP catalogue suggesting novel functions. For example, SRP54, a signal recognition peptide of the P-
loop NTH superfamily was shown to play an important role in the splicing of tau gene [39]. Another 
example from the Spectrin repeat superfamily is RRBP1, a membrane protein of the Endoplasmic 
reticulum(ER) that plays a role in the ER proliferation, mediating ER-microtubule interactions and 
enhancing the association of certain mRNA to ER [40]. Additionally, superfamilies RBD, KH-domain 
type1 and CCCH zinc finger were found to be highly populated with classical proteins whereas WD40 
repeat like and beta-beta-alpha zinc finger (BBA-Zinc finger), ubiquitin-like superfamilies were 
enriched with non-classical proteins (Figure 1D). These analyses together suggests that in addition to 
binding to the RNA molecules, RBPs could also function as an integral part in maintaining cellular 
integrity and architecture.   
RBPs exhibit significant intrinsic disorder and are enriched among the hubs in protein 
interaction networks 
Intrinsically disordered proteins or natively disordered proteins lack a stable secondary and/or 
tertiary structure either completely or in part. They are often observed to be playing a major role in 
signalling, control and regulation, where interaction with more than one protein becomes necessary. 
Intrinsically disordered proteins are characterised by a structural feature called “Intrinsic disorder” 
that enables them to participate in varied cellular functions [41, 42]. RBPs being diverse structurally 
and functionally, are known to be highly disordered [43, 44]. Intrinsic structural disorder of the RBPs 
was predicted using IUPRED, which predicts disorder on a per-residue basis [22, 23] (Materials and 
Methods). The disorder score predicted by IUPRED was normalized by protein length to account for 
variations in different protein lengths when comparing predictions for entire dataset. A protein with a 
normalized score higher than 0.5 was considered to be disordered; this resulted in 30% of RBPs being 
highly disordered (Supplementary Table 2). To test if RBPs are highly disordered than the rest of the 
proteome, we calculated an enrichment of disordered proteins in RBPs taking Non-RBPs as a control. 
This suggested that RBPs are highly unstructured when compared to the Non-RBPs (p<2.2e-16; 
Fisher’s exact test) (Figure 2A). Although RBPs were found to be significantly enriched for disorder 
compared to the non-RBPs, we also observed that the proportion of RBPs which are ordered is 
significantly higher than the disordered RBPs.  Additionally, classical proteins were observed to be 
significantly disordered compared to the non-classical proteins (p-value < 0.001, Fishers exact test) 
(Figure 2B). Proteins, irrespective of whether ordered or disordered do not function in isolation; 
instead, they interact with other proteins or cofactors to perform a biological function. Thus, resulting 
in protein-protein interaction networks, the study of which was enabled by the advent of high-
throughput technologies [45]. Advances in the field of structural biology of proteins and protein-
protein interactions enabled researchers to put these networks in the context of protein 3D structure. 
Studies show that the network properties of disordered proteins is different from those which are 
ordered. Intrinsically disordered proteins are known to be highly interacting due to their unstable 3D 
structure and hence form hubs in their protein-protein interaction networks [44, 46, 47]. This 
property of disordered proteins being hubs in their protein-protein interaction network has been 
analysed in our current study. The protein-protein interaction network for proteins encoded in the 
human genome was constructed using the annotations available in BIOGRID (3.2.106) [48]. This 
resulted in a network of 14,897 proteins yielding 1,27,586 interactions with 1095 hubs. Hubs were 
defined as nodes which interact with at least 50 proteins. On comparison, it was observed that ~30% 
of the hubs constitute RBPs, of which ~25% are disordered. Also, the disordered hub proteins were 
seen to be enriched for RBPs when compared to the Non-RBPs (p = 0.0003, Fisher’s exact test). The 
PPI network revealed that the hubs in the network are enriched for RBPs (p<2.2e-16, Wilcox test). 
These observations imply a highly connected and dynamic role of RBPs via the formation of RNP 
complexes in the regulation of cellular events. 
RBPs are highly conserved across species 
Genes and their functionality can vary across species. In particular, regulatory processes are subject to 
change during the course of evolution and could be a major basis of phenotypic diversity and 
evolutionary adaptation [49]. Therefore, we aimed to study the conservation of genes coding for RBPs 
across different species to gain insight into their regulatory functions. For all the RBPs, we identified 
one-to-one, one-many and many-to many orthologs across 62 different species from ENSEMBL(v73) 
(http://www.ensembl.org) (Materials and Methods, Supplementary Table 3). A hierarchical complete 
linkage clustering of the data (Figure 3A) revealed that 95% of the RBPs have orthologs in at least 50% 
of the species reflecting extensive conservation of various post-transcriptional processes like RNA 
splicing and ribosome biogenesis. This was especially evident because RBPs were significantly highly 
conserved compared to the rest of the genome (Median conservation 55 vs 0 species, p<2.2E-16, 
Wilcox test). We further binned RBPs into three classes based on their conservation level - high, 
medium and low. RBPs with orthologs in more than 80% of the species have high conservation level 
(Figure 3B shows selected set from this class). These include members of the PUM family (PUM1 and 
PUM2), which are a highly conserved family of eukaryotic RBPs [50] . Other examples of highly 
conserved RBPs include ELAVL2 – an RBP which has an important and evolutionary conserved role 
in embryogenesis [51], ADARs (ADAR1, ADAR2) - family of RNA editing enzymes, RBM19 [52] - a 
nucleolar protein that regulates ribosome biogenesis. The next level of conservation is medium 
(Figure 3C) which comprises of RBPs with orthologs in more than 50% but less than 80% of the 
species. Genes in this class include MECP2 - a protein important in the function of nerve cells, which 
is found to be conserved in Mammals, Primates and Vertebrates and ZFP36 - an important player in 
inflammatory responses, conserved in most species except aves (Chicken, Flycatcher, Turkey, Zebra 
finch, Duck) [53]. The low conservation class (Figure 3D) comprised of genes having orthologs in less 
than 50% of the species. Genes in this group included DCD- an antimicrobial peptide coding gene, 
member of the APOBEC family which are specific to primates and mammals [54]. Furthermore, 
nLRP11 – a member of the Nod-like receptor protein family was observed to be present only in 
mammals [55]. Analysis of the variations in the extent of conservation between classical and non-
classical RBPs across species showed that there is no significant difference (p=0.1, Fishers exact 
test)(Figure 3E). These observations highlight that RBPs are evolutionarily highly conserved, with 
classical and non-classical RBPs exhibiting no significant difference in their evolutionary trajectories. 
Additional analysis to study the relation between conservation levels of RBPs and their intrinsic 
disorder indicated that while majority (71%) of the highly conserved RBPs are highly ordered we 
found that 29% of the highly conserved RBPs (See Supplementary Figure 1) were found to be 
significantly disordered (versus 14% for non-RBPs, Odds Ratio = 2.6, p< 2.2e-16, Fishers exact test) 
suggesting that even the highly conserved RBPs are significantly over-represented for structural 
disorder. 
Majority of the RBPs exhibit tissue-specific protein expression levels 
We examined the expression patterns of RBPs across 17 adult tissues and 6 hematopoietic cells from 
recently published human proteome catalogue [24]. A complete linkage hierarchical clustering of the 
expression levels (Figure 4A) groups tissues exhibiting similar levels of expression. Further, the tissue 
specificity of the expression pattern was estimated using an index [25, 26] that varies between zero 
(for housekeeping genes) and one (observed for tissue specific genes). Genes that resulted in an index 
of 0.7 or higher were termed tissue-specific and the rest of them were classified as ubiquitous 
(Materials and Methods, Supplementary Table 4). The ubiquitous category (Figure 4B shows selected 
set) comprised 40% of the RBP catalogue and included several well-known proteins such as the 
polypyimidine tract binding protein PTBP1 [56], polyadenylate binding nuclear protein PABPN1 [57], 
member of the 14-3-3 family YWHAE [58] and Decorin(DCN), a proteoglycan important in collagen 
fibrillogenesis [59]. In addition to these proteins, the ubiquitous category is highly enriched with the 
components of the spliceosome (SRSF9, SRSF2, U2AF1, HNRNPL) and proteasome (UBC, UBE2I, 
UBE2D3). Majority of the RBPs (60%) constituted tissue-specific category (Figure 4C) and included 
heat response protein 12, HRSP12, known to be expressed in kidney and liver [60], DAZL - a germ cell 
specific RBP [61], member of the CELF family CELF3 that is highly expressed in brain [62], PUF60-
poly-U binding splicing factor 60kDa, that was recently shown to be required for the splicing of a 
subset of tissue-specific splicing events which when deregulated in the absence of PUF60 affect the 
development of organs such as brain, heart, kidney and eye [63]. Analysis of the comparison of 
expression patterns of classical and non-classical RBPs in each of the 16 tissues revealed that in ~50% 
of the tissues, the expression of non-classical RBPs was significantly higher than the classical RBPs 
(p<0.05, Wilcoxon test) (Figure 4D). While this relative higher expression of non-classical RBPs could 
be largely attributed to the presence of ribosomal proteins in the non-classical group, these 
observations suggest the prominent role likely played by both groups of proteins in diverse tissues in 
post-transcriptional regulatory control (See Supplementary Table 4). 
RBPs are significantly associated with inflammatory diseases and immune responses 
Aberrant expression of RBPs is associated with several disorders including cancer and 
neurodegenerative diseases [5, 64]. So in order to better understand the disease associations of RBPs, 
we obtained diseases annotations for RBPs from Malacards database [28] (Materials and Methods). 
We evaluated the enrichment of RBPs in various disorders to identify disorders that are highly 
associated with RBPs. Of all the disorders annotated for human genes in malacards, 165 were found to 
be highly enriched for RBPs (p<1e-05, FDR<1% and number of annotated RBPs >10) which included 
all major types of cancers -breast, lung, prostate and liver as well as neurodegenerative diseases-
Parkinson’s disease and down syndrome (Figure 5A). For example, genes like ELAV1, which regulate 
mRNA stability are known to contribute to breast cancer [65], RBM5, a tumor suppressor gene is 
known to control cell growth in lung cancer [66], UPF1, subunit of the post splicing multi protein 
complex is shown to be dysregulated in prostate cancer [67]. RBPs that are known to be dysregulated 
in neurodegenerative diseases include members of the NOVA family [68], QKI, a candidate gene for 
schizophrenia [69] and ELAVL4, an important player in parkinson’s disease [70]. In addition to these 
disorders, RBPs were enriched in various inflammatory diseases such as neuronitis, prostatitis, 
esophagitis suggesting an important role for RBPs in mediating inflammatory responses. For example, 
a cold inducible RNA binding protein (CIRBP) that triggers inflammatory responses in hemarragic 
shock and sepsis was observed to be associated with endothelitis and hypoxia [71]. These results 
suggest that RBPs are not only implicated in cancers and neurodegenerative diseases but also play an 
important role in mediating various immunological responses. The anatomical contexts associated 
with the 165 diseases were studied to get an insight into the cells/tissues that are majorly affected by 
an abnormal expression of RBPs. Anatomical contexts like B cells, T cells , monocytes, fetal liver ,fetal 
brain were observed to be enriched(p<0.001, Hypergeometric test) (Figure 5B). For example, ELAVL1 
is known to regulate various gene expression programs during the embryonic development in mouse 
[72]. Recently, the phenomenon of intron retention was observed at a high level in T cells with 
increased expression of hnRNPL, whereas the introns were efficiently spliced out in  cells that had 
normal/less expressed hnRNPL [73]. Additionally, another independent study identified a RNA 
Binding domain in the thyroid receptor and these receptors are single stranded RNA Binding Proteins 
[74]. All these observations further emphasize the under-appreciated role of RBPs in mediating 
inflammatory and immune responses. Further, we have also analysed the proportion of each class of 
RBPs in each of the enriched diseases and identified that diseases like Pancreatitis and Endotheliitis 
have higher proportion of non-classical RBPs (See Supplementary Table 5 and Supplementary Figure 
2). This observation suggests an increased prevalence of non-classical RBPs in some inflammatory 
diseases. In addition, we also calculated the proportion of RBPs that are ubiquitously expressed or 
tissue specific in their expression patterns, for each enriched disease. This analysis revealed 55 
enriched diseases - one-third of the total diseases significantly enriched for RBPs, to have a significant 
proportion of ubiquitously expressed RBPs (p < 0.01, Fishers exact test, Supplementary Figure 3). We 
also found that only 16 diseases exhibited a prevalence for tissue-specific RBPs compared to 
ubiquitous ones. Since many of the 165 diseases enriched for RBPs are complex multigenic disorders, 
these results support the notion that majority of these diseases are enriched with RBPs which are 
expressed in multiple tissues and hence their observed phenotypic contributions might extend beyond 
the tissue of origin. 
Conclusions 
RNA Binding proteins are major players mediating the post-transcriptional regulation and dearth in 
data has limited our understanding on their regulatory mechanisms and interactions for several years. 
Recent advances in various experimental methods has led to an expansion of the RBPome and thus 
unravelling the RNA binding ability of several proteins. In this study, we present a meta-analysis of 
the RBP catalogue to study their domain architecture, protein structural disorder, tissue wide 
expression, evolutionary conservation and their role in the disease context. We identified several RBPs 
to have domains that are not known for their role in facilitating the function of an RBP (termed as 
“Unclassified” in the present study). This analysis would broaden the scope for researchers in the field 
of proteomics to explore the unknown functions of these domains in mediating post-transcriptional 
regulatory control. For instance, several genes currently annotated as bonafide kinases can also 
function as RNA-binding proteins, so it remains unclear how their interplay between post-
translational and post-transcriptional regulation would drive specific cellular signalling events. It is 
also unclear whether such signalling proteins would also form RNP complexes as do the canonical 
RNA-binding proteins. Our results also show that RBPs are highly unstructured when compared to 
the non-RBPs and are over-represented to be occurring as the hubs of the protein-protein interaction 
networks, suggesting a likely occurrence of their dynamic RNP complexes in the cell. Analysis of the 
extent of conservation of RBPs clearly revealed that RBPs are preserved across majority of the species 
studied here suggestive of a wider conservation of post-transcriptional processes. Our data also 
supports that while majority of the highly conserved RBPs are highly ordered, we found that even the 
highly conserved RBPs are significantly over-represented for structural disorder compared to non-
RBPs indicating the importance of their disorder in the formation and maintenance of RNPs. Since 
RBPs predominantly function by forming RNP complexes it would be interesting to dissect their 
interplay with other protein partners in various cell types such as immune cells, where currently there 
is limited understanding of either their RNP complexes or post-transcriptional regulatory networks 
they govern. Our analysis of expression data revealed that RBPs are largely tissue specific in their 
protein levels. Disease association analysis of RBPs showed a clear enrichment for their association 
with several inflammatory diseases and immune responses among other complex disease phenotypes 
such as cancer and neurological disorders. RBPs associated with these complex disorders were also 
found to be over-represented for ubiquitously expressed RBPs. Together, this analyses uncovers 
several characteristics of ~1300 RBPs which would help researchers in the field of proteomics to 
develop strategies that can target specific RBPs of interest to gain further insights into their function 
in specific tissues and disease states.   
Majority of the RNA binding proteins in this study are unclassified and uncharacterised for their 
protein domains which bind to RNA or mediate RNA binding. So future computational and 
experimental efforts should be able to uncover the specific protein domains which can bind and 
recognize the RNA species in the cell. Our results also suggest that RBPs are highly unstructured when 
compared to the rest of the proteome implying an active role of RBPs in regulating cellular events. 
This study also expands the existing knowledge on tissue expression patterns of RBPs, their 
evolutionary conservation and disease associations. Altogether, providing a snapshot of the 
characteristics of RNA Binding proteins and will be a valuable resource to unravel many 
unconventional, novel functions and dynamics of RNP complexes in the context of post-
transcriptional regulatory networks. 
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Figure 1: Domain Architecture of RNA Binding Proteins| Pfam domains listed by Castello et 
al (2012) to define classical and non-classical RBPs were used to annotate the RBP catalogue. Those 
that could not be classified into either of the categories were termed ‘Unclassified’. Figure A shows the 
overall domain distribution in RNA binding proteins. Figure B shows the distribution of individual 
pfam domains in RBPs. Figure C shows the distribution of various superfamilies’ of RBPs (* against 
the Superfamily name indicates that the name has been abbreviated). Superfamilies’ like P-loop 
nucleoside triphosphate hydrolases (P-loop NTH), beta-beta-alpha zinc finger (BBA-Zinc finger) were 
found to be enriched in RBPs when compared to the Non-RBPs (** indicates p<0.05, Fisher’s exact 
test). Figure D shows the distribution of classical and non-classical RBPs in each superfamily. In all 
the figures 1B,1C,1D domains and superfamilies’ associated with less than 1% of the RBPs are not 
shown. 
Figure 2: Intrinsic Disorder of RNA Binding Proteins| The extent of disorder was predicted 
using IUPred. A protein was considered to be disordered if the normalized disorder score is greater 
than 0.5. Figure A compares the intrinsic disorder between RBPs and Non-RBPs suggesting RBPs to 
be more disordered than Non-RBPs (p<2.2e-16, Fisher’s exact test). Figure B compares the intrinsic 
disorder between the classical and non-classical RBPs showing classical RBPs to be more disordered 
than the non-classical (p<2.2e-16, Fisher’s exact test). 
Figure 3: Evolutionary conservation of RBPs| A complete linkage hierarchical clustering of 
RBP orthologs in 62 different species illustrating high conservation levels (Figure A). Based on their 
conservation levels, RBPs were categorized into three levels - high (conservation in >=80% of the 
species), medium (conservation in >=50% and <=80% of the species), low (conservation in <=50% of 
the species). Figure B shows a subset of RBPs that are highly conserved. Figure C, a subset of RBPs 
which exhibited medium level of conservation. Figure D shows RBPs that are poorly conserved. Figure 
E compares the extent of conservation in classical and non-classical RBPs suggesting similar 
conservation patterns in the two groups (p=0.1, Fisher’s exact test). 
Figure 4: Tissue-wide expression patterns of RBPs| Expression of  RBPs across 25 different 
tissues obtained from the human protein catalogue [24]. Complete linkage hierarchical clustering of 
the expression data is shown in Figure A. Based on the expression patterns, RBPs were classified as 
ubiquitous and tissue-specific [26]. Figure B and C show a subset of RBPs that are ubiquitous and 
tissue-specific respectively. Figure D compares the expression levels of classical and non-classical 
RBPs in each tissue (* indicates p<0.05, Wilcoxon test). 
Figure 5: Diseases and anatomical contexts associated with RBPs| Diseases enriched for 
RBPs were obtained by using the annotations available from the malacards database [28] and filtered 
for at least 10 RBP associations, p-value < 1e-05 and FDR <1%. Among these, top 50 are displayed in 
the figure (Figure A) and the complete list is available as Supplementary Table 5. Figure 5B shows the 
top 20 anatomical contexts significantly associated with diseases enriched for RBPs (p<0.001, Fishers 
exact test). A complete list is available as Supplementary Table 5. 
 Supplementary Tables 
Supplementary Table 1: Detailed catalogue of RBPs and their domain architecture 
Supplementary Table 2: Intrinsic Disorder of RNA Binding Proteins 
Supplementary Table 3: Ortholog Information 
Supplementary Table 4: Expression levels of RBPs across tissues 
Supplementary Table 5: Disease associations 
 
Supplementary Figures  
Figure 1: Scatter plot showing the conservation levels vs the disorder score for all the 
RBPs. 
Figure 2: Top 50 enriched diseases with the proportion of Classical, Non-classical and 
Unclassified RBPs. 
Figure 3: Diseases with significant over-representation of ubiquitous RBPs compared to 
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